US regulators find contaminants in unapproved OTC eye drops in packaging intended to resemble a popular brand three months after it appeared they’d reached the end of an extended trail of problems with ophthalmic products.
The Food and Drug Administration recently warned consumers not to purchase or use eye drops sold under the brands FivFivGo, Rebright and South Moon because of the potential risk of...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?